More Articles

The Dispatch E-Edition

All current subscribers have full access to Digital D, which includes the E-Edition and
unlimited premium content on Dispatch.com, BuckeyeXtra.com, BlueJacketsXtra.com and
DispatchPolitics.com.
Subscribe
today!

Abbott Laboratories Inc. must pay $700 million in fines and other costs for illegal marketing of
its drug Depakote, in line with a previously announced settlement, the U.S. Justice Department said
yesterday.

The drugmaker said in May that it would plead guilty to a misdemeanor violation of misbranding
and pay $1.6 billion to state and federal authorities.

Abbott marketed Depakote for conditions, including depression, without government approval for
those uses, prosecutors said.